American Diabetes Association’s “Standards of Medical Care in Diabetes” is based on a complete review of the relevant literature by a diverse group of highly trained clinicians and researchers. After weighing the quality of evidence, from rigorous double-blind clinical trials to expert opinion, recommendations are drafted, reviewed, and submitted for approval to the American Diabetes Association Executive Committee. Access the 2022 Standards of Care at diabetesjournals.org/care/issue/45/Supplement_1.

Presented by the American Diabetes Association’s Chief Scientific and Medical Officer, Robert Gabbay, MD, PhD, this webcast presents the key updates and highlights from Standards of Medical Care in Diabetes—2022. To access the webcast, please visit professional.diabetes.org/SOC.

The 36th Annual Clinical Conference on Diabetes will be held in Ponte Vedra Beach, Florida, on 26–29 May 2022 at the Sawgrass Marriott Golf Resort & Spa. The ADA Clinical Conference is designed specifically for primary care physicians, physician associates, nurse practitioners, pharmacists, nurses, psychologists, dietitians, certified diabetes educators, and other health care professionals who care for patients with diabetes or those at risk for diabetes and who manage diabetes-related complications. For registration details and more information, please visit professional.diabetes.org/meeting/other/36th-annual-clinical-conference-diabetes.

The 82nd annual American Diabetes Association Scientific Sessions will be held in New Orleans, Louisiana, on 3–7 June 2022, at the Ernest N. Morial Convention Center. The largest of its kind, this meeting brings together scientists and health care professionals from around the world who are involved in diabetes research and care. Attendees choose from thousands of original presentations given by leading experts in the field. The American Diabetes Association is currently planning a hybrid event. For more information, please visit professional.diabetes.org/scientific-sessions.

ADA’s most recently published clinical compendium summarizes the latest information about screening for, diagnosing, and treating painful diabetic peripheral neuropathy in routine clinical practice. This monograph is supported by unrestricted education grant from Nevro, Inc. To access this and other clinical compendia for free, visit professional.diabetes.org/monographs.

The American Diabetes Association is making strides to increase experts in the field and ensure support for the psychosocial challenges faced as we continue to help people with diabetes and their families thrive. To view a list of resources, including a mental health toolkit and video on-demand program, please visit professionaleducation.diabetes.org.

The ADA's Overcoming Therapeutic Inertia (OTI) CE Certificate program is designed to empower clinicians caring for people with diabetes with knowledge and strategies to be a barrier buster. The OTI Certificate bundle allows clinicians to access all OTI modules at a discounted price in addition to various exclusive benefits. For more information on this and other available programs, please visit professionaleducation.diabetes.org.

© 2022 by the American Diabetes Association
2022
Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. More information is available at https://www.diabetesjournals.org/content/license.